Literature DB >> 31825487

2019 Endocrine Society Measures Set for Older Adults With Type 2 Diabetes Who Are at Risk for Hypoglycemia.

James L Rosenzweig1, Paul R Conlin2, Jasmine D Gonzalvo3, Stephanie B Kutler4, Nisa M Maruthur5, Penelope Solis6, Sandeep Vijan7, Amisha Wallia8, Robin Fein Wright9.   

Abstract

CONTEXT: Hypoglycemia in the outpatient setting has a significant financial impact on the health care system and negative impact on a person's quality of life. Primary care physicians must address a multitude of issues in a visit with a person with type 2 diabetes mellitus (T2DM), often leaving little time to ask about hypoglycemia.
OBJECTIVE: To develop quality measures that focus on outpatient hypoglycemia episodes for patients 65 and older with T2DM, which facilitate a clinician's ability to identify opportunities to improve the quality of care and reduce hypoglycemic episodes. PARTICIPANTS AND PROCESS: A technical expert panel established by the Endocrine Society in March 2019, which includes endocrinologists, primary care physicians, a diabetes care and education specialist/pharmacist, and a patient, developed 3 outpatient hypoglycemia quality measures. The measure set is intended to improve quality of care for patients with T2DM who are at greatest risk for hypoglycemia. The measures were available for public comment in July 2019. A fourth measure on shared decision-making was removed from the final measure set based on public feedback.
CONCLUSION: A lack of outpatient hypoglycemia measures focusing on older adults with T2DM is a barrier to improving care of people with diabetes and reducing hypoglycemic episodes. This paper provides measure specifications for 3 measures that may be used to focus quality improvement efforts on patients at greatest risk for hypoglycemia. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  diabetes; diabetes medications; hypoglycemia; older adults; performance measures; quality improvement; type 2 diabetes

Year:  2020        PMID: 31825487     DOI: 10.1210/clinem/dgz250

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study.

Authors:  Takahisa Handa; Akinobu Nakamura; Aika Miya; Hiroshi Nomoto; Hiraku Kameda; Kyu Yong Cho; So Nagai; Narihito Yoshioka; Hideaki Miyoshi; Tatsuya Atsumi
Journal:  Diabetol Metab Syndr       Date:  2021-04-01       Impact factor: 3.320

2.  Switching from Neutral Protamine Hagedorn (NPH) Insulin to Insulin Glargine 300 U/mL in Older and Younger Patients with Type 2 Diabetes: A Post Hoc Analysis of a Multicenter, Prospective, Observational Study.

Authors:  B Wolnik; A Hryniewiecki; D Pisarczyk-Wiza; T Szczepanik; T Klupa
Journal:  Diabetes Ther       Date:  2022-01-16       Impact factor: 3.595

3.  Lobar Cerebral Microbleeds Are Associated With Cognitive Decline in Patients With Type 2 Diabetes Mellitus.

Authors:  Pengfei Shao; Hengheng Xu; Xiaoning Sheng; Ruomeng Qin; Junyi Ma; Yishan Luo; Allan Lee; Lin Shi; Lili Huang; Yue Cheng; Hui Zhao; Yun Xu
Journal:  Front Neurol       Date:  2022-03-25       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.